Summary
Augmentation of the phytohemagglutinin (PHA)-induced lymphoproliferation of peripheral blood mononuclear cells by indomethacin, a drug which blocks prostaglandin (PG) synthesis, was assessed in 37 patients with squamous cell carcinoma of the head and neck. Indomethacin enhanced the uptake of 3H-thymidine in stimulated cultures both from patients and normal individuals. However, because lymphoid cells from cancer patients were less reactive than those from normal controls, the proportionate increase in PHA-stimulated 3H-thymidine incorporation caused by indomethacin was greater in this population than in the normal population. The degree of enhancement induced by indomethacin did not correlate with the percent of esterase-positive mononuclear cells in the preparations. The amounts of PGE synthesized at 48 h by patients' or normal cells were similar. Cell populations that exhibited elevated levels of augmentation in the presence of indomethacin were approximately 3 times as sensitive to inhibition by 3 nM PGE2. The degree of augmentation detected in the presence of Ro-20-5720, which also prevents PG synthesis, was related to that produced by indomethacin. These results suggested that: (1) the enhancing effect of indomethacin on lymphoproliferation in vitro was related to its inhibition of PG synthesis; and (2) the sensitivity of lymphoid cells to inhibition by PGE2 was slightly, but significantly, increased in individuals with elevated augmentation values.
Similar content being viewed by others
References
Al-Saleem T, Ali ZS, Qassab M (1980) Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids. Lancet II:264
Bennett A (1979) Prostaglandins and cancer. In: Karim SMM (ed) Practical applications of prostaglandins and their synthesis inhibitors. MTP Press, Lancaster, p 149
Berlinger, NT, Hilal EY, Oettgen, HF, Good RA (1978) Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells. Laryngoscope 88:470
Braun DP, Harris JE (1984) Effect of combination chemotherapy on PGE-mediated immunoregulation in the peripheral blood mononuclear cells of solid tumor cancer patients. J Biol Response Mod 3:391
Braun DP, Harris JE (1984) Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2. J Biol Response Mod 3:533
Braun DP, Cobleigh MA, Harris JE (1980) Multiple concurrent immunoregulatory defects in cancer patients with depressed PHA-induced lymphocyte DNA synthesis. Clin Immunol Immunopathol 17:89
Braun DP, Penn RD, Flannery AM, Harris JE (1982) Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas. Neurosurgery 10:203
Braun DP, Nisius S, Hollinshead A, Harris JE (1983) Serial immune testing in surgically resected lung cancer patients. Cancer Immunol Immunother 15:114
Browder JP, Chretien PB (1977) Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials. Sem Oncol 4:431
Carter CA, Milholland RJ, Shea W, Ip MM (1983) Effect of the prostaglandin synthetase inhibitor indomethacin on 7, 12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res 43:3559
Chouaib S, Chatenoud L, Klatzmann D, Fradelizi D (1984) The mechanisms of inhibition of human IL2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol 132:1851
Dawson DE, Everts EC, Vetto RM, Burger DR (1985) Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 94:342
DeGowin RL, Gibson DP (1981) Prostaglandin-mediated enhancement of erythroid colonies by marrow stromal cells (MSC). Exp Hematol 9:274
DeShazo RD (1980) Indomethacin-responsive mononuclear cell dysfunction in Hodgkin's disease. Clin Immunol Immunopathol 17:66
Flower RJ (1974) Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26:33
Fulton AM (1984) In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res 44:2416
Goldyne ME, Stobo JD (1980) Prostaglandin E2 as a modulator of macrophage-T lymphocyte interactions. J Invest Dermatol 74:297
Goodwin JS, Webb DR (1980) Regulation of the immune response by prostaglandin. Clin Immunol Immunopathol 15:106
Goodwin JS, Messner RP, Bankhurst AD, Peak GT, Saiki JH, Williams RC Jr (1977) Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med 297:963
Goodwin JS, Bankhurst AD, Murphy SA, Selinger DS, Messner RP, Williams RC Jr (1978) Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J Clin Lab Immunol 1:197
Goodwin JS, Selinger DS, Messner RP, Reed WP (1978) Effect of indomethacin in vivo on humoral and cellular immunity in humans. Infect Immun 19:430
Goodwin JS, Bromberg S, Staszak C, Kaszubowski PA, Messner RP, Neal JF (1981) Effect of physical stress on sensitivity of lymphocytes to inhibition by prostaglandin E. J Immunol 127:518
Hayashi Y, Nishida T, Yoshida H, Yanagawa T, Yura Y, Furumoto N, Sato M (1984) Peripheral T γ lymphocyte population in head and neck cancer. Cancer Immunol Immunother 17:160
Hirsch B, Johnson JT, Rabin BS, Thearle PB (1983) Immunostimulation of patients with head and neck cancer. Arch Otolaryngol 109:298
Kantor HS, Hampton M (1978) Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase. Nature 276:841
Kollmorgen GM, King MM, Kosanke SD, Do C (1983) Influence of dietary fat and indomethacin on the growth of transplantable mammary tumors in rats. Cancer Res 43:4714
Koski IR, Poplack DG, Blaese RM (1976) A nonspecific esterase stain for the identification of monocytes and macrophages. In: Bloom BR, David JR (eds) In vitro methods in cell-mediated and tumor immunity. Academic Press, New York, p 359
Lewis GP (1983) Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull 39:243
Lynch NR, Castes M, Astoin M, Salomon JC (1978) Mechanism of inhibition of tumor growth by aspirin and indomethacin. Br J Cancer 38:503
Maca RD, Panje WR (1982) Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and post irradiation therapy. Cancer 50:483
Mavligit GM, Raphael LS, Calvo DB III, Wong WL (1980) Indomethacin-induced, monocyte-dependent restoration of local graft-versus-host reaction among cells from cancer patients. J Natl Cancer Inst 65:317
Murray JL, Springle C, Ishmael DR, Lee ET, Longley R, Kollmorgen GM, Nordquist RL (1981) Adherent indomethacin-sensitive suppressor cells in malignant melanoma. Correlation with clinical status. Cancer Immunol Immunother 11:165
Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A (1981) Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 41:1954
Panje WR (1981) Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Orolaryngol 107:658
Panje WR (1983) Prostaglandin synthesis inhibitor in the treatment of head and neck cancer. In: Rhys Evans PH, Robin PE, Fielding JWL (eds) Head and neck cancer. Castle House Publications Ltd, Tunbridge Wells, p 105
Pelus LM, Strausser HR (1976) Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int J Cancer 18:653
Plescia OJ (1982) Does prostaglandin synthesis effect in vivo tumour growth by altering tumor/host balance? In: Powles TJ, Bockman RS, Honn KV, et al (eds) Prostaglandins and cancer: first international conference. Alan R Liss, Inc, New York, p 619
Plescia OJ, Smith AH, Grinwich K (1975) Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci USA 72:1848
Pollard M, Luckert PH (1980) Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 64:1323
Pollard M, Luckert PH (1981) Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 214:558
Powles TJ, personal communication to Bennett A, ref 2, p 170
Stockman GD, Mumford DM (1974) The effect of prostaglandins on the in vitro blastogenic response of human peripheral blood lymphocytes. Exp Hematol 2:65
Stoll BA (1973) Indomethacin in breast cancer. Lancet II:384
Strausser HR, Humes JL (1975) Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in BALB/c mice. Int J Cancer 15:724
Tilden AB, Balch CM (1981) Indomethacin enhancement of immunocompetence in melanoma patients. Surgery 90:77
Tilden AB, Dougherty PA, Balch CM (1982) Differential effects of indomethacin and PGE2 on the depressed responses of cancer patients. In: Powles TJ, Bockman RS, Honn KV, et al. (eds) Prostaglandins and cancer: first international conference. Alan R Liss, Inc, New York, p 651
Trevisani A, Ferreti E, Capuzzo A, Tomasi V (1980) Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumor growth by non-steroidal anti-inflammatory drugs. Br J Cancer 41:341
Vosixa G, Thies J (1979) Effect of indomethacin on blastogenesis of lymphocytes from cancer patients: differentiation of patient types. Clin Immunol Immunopathol 13:30
Waddell WR, Gerner RE (1980) Indomethacin and ascorbate inhibit desmoid tumors. J Surg Oncol 15:85
Young MR, Knies S (1984) Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo. J Natl Cancer Inst 72:919
Zighelboim J, Dorey F, Parker NH, Calcaterra T, Ward P, Fahey JL (1979) Immunologic evaluation of patients with advanced head and neck carcinoma receiving weekly chemoimmunotherapy. Cancer 44:117
Author information
Authors and Affiliations
Additional information
A portion of this study was completed at the Division of Head and Neck Surgical Oncology, Department of Otolaryngology-Head and Neck Surgery, The University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
Rights and permissions
About this article
Cite this article
McCormick, K.J., Panje, W.R. Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer. Cancer Immunol Immunother 21, 226–232 (1986). https://doi.org/10.1007/BF00199366
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199366